Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain?: A commentary on the NSABP-B35 trial

Kirsty E. Stuart; John Boyages

doi:10.21037/tcr.2016.06.11

Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain? A commentary on the NSABP-B35 trial

Kirsty E. Stuart^*, John Boyages

^*Corresponding author for this work

Faculty of Medicine, Health and Human Sciences

Research output: Contribution to journal › Comment/opinion › peer-review

Original language	English
Pages (from-to)	S113-S116
Number of pages	4
Journal	Translational Cancer Research
Volume	5
DOIs	https://doi.org/10.21037/tcr.2016.06.11
Publication status	Published - Jun 2016

Access to Document

10.21037/tcr.2016.06.11

Cite this

@article{7bdcc012a0574cbc98897e887f2d1024,

title = "Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain?: A commentary on the NSABP-B35 trial",

author = "Stuart, {Kirsty E.} and John Boyages",

year = "2016",

month = jun,

doi = "10.21037/tcr.2016.06.11",

language = "English",

volume = "5",

pages = "S113--S116",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain?

T2 - A commentary on the NSABP-B35 trial

AU - Stuart, Kirsty E.

AU - Boyages, John

PY - 2016/6

Y1 - 2016/6

UR - http://www.scopus.com/inward/record.url?scp=84991794209&partnerID=8YFLogxK

U2 - 10.21037/tcr.2016.06.11

DO - 10.21037/tcr.2016.06.11

M3 - Comment/opinion

AN - SCOPUS:84991794209

SN - 2218-676X

VL - 5

SP - S113-S116

JO - Translational Cancer Research

JF - Translational Cancer Research

ER -

Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain? A commentary on the NSABP-B35 trial

Access to Document

Other files and links

Cite this